These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

909 related articles for article (PubMed ID: 20872215)

  • 41. Effect of strontium ranelate on lumbar spine bone mineral density in women with established osteoporosis previously treated with teriparatide.
    Anastasilakis AD; Polyzos SA; Avramidis A; Papatheodorou A; Terpos E
    Horm Metab Res; 2009 Jul; 41(7):559-62. PubMed ID: 19204890
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Strontium ranelate: a review of its use in the treatment of postmenopausal osteoporosis.
    Deeks ED; Dhillon S
    Drugs; 2010 Apr; 70(6):733-59. PubMed ID: 20394457
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [New treatments in osteoporosis].
    Chapurlat R; Delmas PD
    Rev Med Interne; 2004 Dec; 25 Suppl 5():S573-9. PubMed ID: 15841950
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Bone remodeling: new therapeutic approaches].
    Ferrari S
    Rev Med Suisse; 2009 Jun; 5(207):1325-8. PubMed ID: 19626933
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Potential anti-catabolic and anabolic properties of strontium ranelate.
    Mentaverri R; Brazier M; Kamel S; Fardellone P
    Curr Mol Pharmacol; 2012 Jun; 5(2):189-94. PubMed ID: 21787286
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Therapeutic innovation in osteoporosis (antisclerostin antibody and denosumab)].
    Quemerais-Durieu MA; Kerlan V; Chabre O
    Ann Endocrinol (Paris); 2011 Oct; 72 Suppl 1():S15-22. PubMed ID: 22008272
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Strontium ranelate improves bone microarchitecture in osteoporosis.
    Hamdy NA
    Rheumatology (Oxford); 2009 Oct; 48 Suppl 4():iv9-13. PubMed ID: 19783592
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The effect of prior bisphosphonate therapy on the subsequent therapeutic effects of strontium ranelate over 2 years.
    Middleton ET; Steel SA; Aye M; Doherty SM
    Osteoporos Int; 2012 Jan; 23(1):295-303. PubMed ID: 21274515
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Comparative effects of teriparatide and strontium ranelate on bone biopsies and biochemical markers of bone turnover in postmenopausal women with osteoporosis.
    Recker RR; Marin F; Ish-Shalom S; Möricke R; Hawkins F; Kapetanos G; de la Peña MP; Kekow J; Farrerons J; Sanz B; Oertel H; Stepan J
    J Bone Miner Res; 2009 Aug; 24(8):1358-68. PubMed ID: 19338452
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Combined Pharmacologic Therapy in Postmenopausal Osteoporosis.
    Shen Y; Gray DL; Martinez DS
    Endocrinol Metab Clin North Am; 2017 Mar; 46(1):193-206. PubMed ID: 28131133
    [TBL] [Abstract][Full Text] [Related]  

  • 51. [Strontium ranelate in post-menopausal osteoporosis].
    Przedlacki J
    Endokrynol Pol; 2011; 62 Suppl 2():23-31. PubMed ID: 22125019
    [TBL] [Abstract][Full Text] [Related]  

  • 52. No difference between strontium ranelate (SR) and calcium/vitamin D on bone turnover markers in women with established osteoporosis previously treated with teriparatide: a randomized controlled trial.
    Anastasilakis AD; Goulis DG; Polyzos SA; Gerou S; Ballaouri I; Efstathiadou Z; Kita M; Avramidis A
    Clin Endocrinol (Oxf); 2009 Apr; 70(4):522-6. PubMed ID: 18625000
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The use of PTH in the treatment of osteoporosis.
    Borba VZ; Mañas NC
    Arq Bras Endocrinol Metabol; 2010 Mar; 54(2):213-9. PubMed ID: 20485911
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Parathyroid Hormone and Parathyroid Hormone-Related Protein Analogs in Osteoporosis Therapy.
    Leder BZ
    Curr Osteoporos Rep; 2017 Apr; 15(2):110-119. PubMed ID: 28303448
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Long-term treatment of osteoporosis in postmenopausal women: a review from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) and the International Osteoporosis Foundation (IOF).
    Cooper C; Reginster JY; Cortet B; Diaz-Curiel M; Lorenc RS; Kanis JA; Rizzoli R
    Curr Med Res Opin; 2012 Mar; 28(3):475-91. PubMed ID: 22356102
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Efficacy of strontium ranelate in combination with a D-hormone analog for the treatment of postmenopausal osteoporosis.
    Abboskhujaeva LS; Ismailov SI; Alikhanova NM
    Drugs R D; 2014 Dec; 14(4):315-24. PubMed ID: 25480348
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Strontium ranelate: an increased bone quality leading to vertebral antifracture efficacy at all stages.
    Ortolani S; Vai S
    Bone; 2006 Feb; 38(2 Suppl 1):19-22. PubMed ID: 16455319
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Strontium ranelate and alendronate have differing effects on distal tibia bone microstructure in women with osteoporosis.
    Rizzoli R; Laroche M; Krieg MA; Frieling I; Thomas T; Delmas P; Felsenberg D
    Rheumatol Int; 2010 Aug; 30(10):1341-8. PubMed ID: 20512336
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Circulating semaphorin-4D and plexin-B1 levels in postmenopausal women with low bone mass: the 3-month effect of zoledronic acid, denosumab or teriparatide treatment.
    Anastasilakis AD; Polyzos SA; Makras P; Gkiomisi A; Sakellariou G; Savvidis M; Papatheodorou A; Kokkoris P; Terpos E
    Expert Opin Ther Targets; 2015 Mar; 19(3):299-306. PubMed ID: 25395071
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Efficacy of strontium ranelate for the mineralization of bone in postmenopausal women].
    Basurto L; Zárate A; Córdova N; Saucedo R; Galván R; Campos S; Hernández M
    Ginecol Obstet Mex; 2009 May; 77(5):227-30. PubMed ID: 19496517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 46.